𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genotype–phenotype correlation in primary carnitine deficiency

✍ Scribed by Emily C. Rose; Cristina Amat di San Filippo; Uzochi C. Ndukwe Erlingsson; Orly Ardon; Marzia Pasquali; Nicola Longo

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
327 KB
Volume
33
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis

Primary carnitine deficiency is caused by defective OCTN2 carnitine transporters encoded by the SLC22A5 gene. Lack of carnitine impairs fatty acid oxidation resulting in hypoketotic hypoglycemia, hepatic encephalopathy, skeletal and cardiac myopathy. Recently, asymptomatic mothers with primary carnitine deficiency were identified by low carnitine levels in their infant by newborn screening. Here, we evaluate mutations in the SLC22A5 gene and carnitine transport in fibroblasts from symptomatic patients and asymptomatic women. Carnitine transport was significantly reduced in fibroblasts obtained from all patients with primary carnitine deficiency, but was significantly higher in the asymptomatic women's than in the symptomatic patients' fibroblasts (P < 0.01). By contrast, ergothioneine transport (a selective substrate of the OCTN1 transporter, tested here as a control) was similar in cells from controls and patients with carnitine deficiency. DNA sequencing indicated an increased frequency of nonsense mutations in symptomatic patients (P < 0.001). Expression of the missense mutations in Chinese hamster ovary (CHO) cells indicated that many mutations retained residual carnitine transport activity, with no difference in the average activity of missense mutations identified in symptomatic versus asymptomatic patients. These results indicate that cells from asymptomatic women have on average higher levels of residual carnitine transport activity as compared to that of symptomatic patients due to the presence of at least one missense mutation.

📜 SIMILAR VOLUMES

Functional analysis of mutations in the
Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: Lack of genotype–phenotype correlation
✍ Yuhuan Wang; Franco Taroni; Barbara Garavaglia; Nicola Longo 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB 👁 2 views

Primary carnitine deficiency is an autosomal recessive disorder of fatty acid oxidation caused by defective carnitine transport. This disease is caused by mutations in the novel organic cation transporter OCTN2 (SLC22A5 gene). The disease can present early in life with hypoketotic hypoglycemia or la

Genotype-phenotype correlation in adult-
Genotype-phenotype correlation in adult-onset acid maltase deficiency
✍ Dr John H. J. Wokke; Margreet G. E. M. Ausems; Marie-José H. van den Boogaard; E 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

We performed a clinical, biochemical, and genetic study in 16 patients from 11 families with adult-onset acid maltase deficiency. All patients were compound heterozygotes and carried the IVS1( --13T+G) transversion on one alkele; the second allele harbored either a deletion of a T at position 525 in

Pharmacological rescue of carnitine tran
Pharmacological rescue of carnitine transport in primary carnitine deficiency
✍ Cristina Amat di San Filippo; Marzia Pasquali; Nicola Longo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB

## Communicated by Nancy Spinner Primary carnitine deficiency is a recessive disorder caused by heterogeneous mutations in the SLC22A5 gene encoding the OCTN2 carnitine transporter. Here we extend mutational analysis to eight new families with this disorder. To determine the mechanism by which miss

Mutational spectrum and genotype–phenoty
Mutational spectrum and genotype–phenotype correlations in mevalonate kinase deficiency
✍ Saskia H.L. Mandey; Marit S. Schneiders; Janet Koster; Hans R. Waterham 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

## Communicated by Johannes Zschocke Mevalonate kinase deficiency (MKD) is an autosomal recessive autoinflammatory disorder caused by mutations in the MVK gene resulting in deficient activity of mevalonate kinase (MK). Depending on the clinical severity, MKD may present as hyper-IgD and periodic fe

Correlation between genotype, metabolic
Correlation between genotype, metabolic data, and clinical presentation in carnitine palmitoyltransferase 2 (CPT2) deficiency
✍ Laure Thuillier; Hidayeth Rostane; Veronique Droin; France Demaugre; Michèle Bri 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Carnitine palmitoyltransferase 2 (CPT2) deficiency, the most common inherited disease of the mitochondrial long-chain fatty acid (LCFA) oxidation, may result in distinct clinical phenotypes, namely a mild adult muscular form and a severe hepatocardiomuscular disease with an onset in the neonatal per